534 related articles for article (PubMed ID: 34013544)
41. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
42. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V
Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785
[TBL] [Abstract][Full Text] [Related]
43. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma.
Cen X; Li M; Yao A; Zheng Y; Lai W
J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069
[TBL] [Abstract][Full Text] [Related]
44. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.
Miyazaki Y; Oda T; Mori N; Kida YS
FEBS Open Bio; 2020 Nov; 10(11):2268-2281. PubMed ID: 32931156
[TBL] [Abstract][Full Text] [Related]
45. Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.
Grout JA; Sirven P; Leader AM; Maskey S; Hector E; Puisieux I; Steffan F; Cheng E; Tung N; Maurin M; Vaineau R; Karpf L; Plaud M; Begue AL; Ganesh K; Mesple J; Casanova-Acebes M; Tabachnikova A; Keerthivasan S; Lansky A; Berichel JL; Walker L; Rahman AH; Gnjatic S; Girard N; Lefevre M; Damotte D; Adam J; Martin JC; Wolf A; Flores RM; Beasley MB; Pradhan R; Muller S; Marron TU; Turley SJ; Merad M; Kenigsberg E; Salmon H
Cancer Discov; 2022 Nov; 12(11):2606-2625. PubMed ID: 36027053
[TBL] [Abstract][Full Text] [Related]
46. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.
Desbois M; Wang Y
Immunol Rev; 2021 Jul; 302(1):241-258. PubMed ID: 34075584
[TBL] [Abstract][Full Text] [Related]
47. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
[No Abstract] [Full Text] [Related]
48. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
49. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
50. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
[TBL] [Abstract][Full Text] [Related]
51. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
[TBL] [Abstract][Full Text] [Related]
53. HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like.
Garufi A; Traversi G; Cirone M; D'Orazi G
IUBMB Life; 2019 Dec; 71(12):2055-2061. PubMed ID: 31414572
[TBL] [Abstract][Full Text] [Related]
54. Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy.
Vienot A; Pallandre JR; Renaude E; Viot J; Bouard A; Spehner L; Kroemer M; Abdeljaoued S; van der Woning B; de Haard H; Loyon R; Hervouet E; Peixoto P; Borg C
Oncoimmunology; 2022; 11(1):2144669. PubMed ID: 36387055
[TBL] [Abstract][Full Text] [Related]
55. Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.
Owen JS; Clayton A; Pearson HB
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671452
[TBL] [Abstract][Full Text] [Related]
56. Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function.
Ramil CP; Xiang H; Zhang P; Cronin A; Cabral L; Yin Z; Hai J; Wang H; Ruprecht B; Jia Y; Sun D; Chen H; Chi A
Oncoimmunology; 2024; 13(1):2300882. PubMed ID: 38192443
[TBL] [Abstract][Full Text] [Related]
57. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
58. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
[TBL] [Abstract][Full Text] [Related]
59. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.
Kieffer Y; Hocine HR; Gentric G; Pelon F; Bernard C; Bourachot B; Lameiras S; Albergante L; Bonneau C; Guyard A; Tarte K; Zinovyev A; Baulande S; Zalcman G; Vincent-Salomon A; Mechta-Grigoriou F
Cancer Discov; 2020 Sep; 10(9):1330-1351. PubMed ID: 32434947
[TBL] [Abstract][Full Text] [Related]
60. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
